Darbas Sule, Inan Dilara, Kilinc Yahya, Arslan Habibe Sema, Ucar Fahri, Boylubay Ozaydin, Koksoy Sadi, Mutlu Esvet, Yucel Burcu, Ekinci Nurten Sayin
Department of Medical Biology and Genetics, Akdeniz University Faculty of Medicine, Antalya, Turkiye.
Department of Infectious Diseases, Akdeniz University Faculty of Medicine, Antalya, Turkiye.
North Clin Istanb. 2022 Dec 13;10(1):67-73. doi: 10.14744/nci.2021.00018. eCollection 2023.
Many human leukocyte antigen (HLA)-B alleles are associated with an increased risk of Acquired Immune Deficiency Syndrome (AIDS) and Human Immunodeficiency Virus (HIV) progression; however, their distribution varies among different racial/ethnic groups. Abacavir used in the treatment of AIDS significantly increases the risk of hypersensitivity reactions in patients with HLA-B57:01. The aim of this study was to determine the distribution of HIV-associated HLA-B subgroups (high and low resolution) and HLA-B57:01 associated with Abacavir sensitivity in Turkiye.
This retrospective case-control study consisted of 416 (F/M:111/305) HIV positive patients and 416 (F/M:111/305) healthy controls. HLA-B alleles were identified using Luminex based low-resolution method and further subgrouped by sequence-based high-resolution typing.
Our data showed that in patients with HIV-1 infection, HLA-B*15, *35, and 51 allele frequencies were higher, while the HLA-B07, *14 and 55 allele frequencies were lower as compared to the controls. It was determined that HLA-B15:01, *35:01, *35:08, and 51:01 alleles frequencies were higher in the patients with HIV-1 infection compared to the controls as HLA-B07:02, *14:01, *44:01, and 55:01 allele frequencies were detected low. HLA-B57:01 allele positivity, which is important in Abacavir hypersensitivity, was lower than controls, and this difference was not statistically significant.
Our results suggest that, HLA-B*07, *14, and 55 alleles and HLA-B07:02, *14:01, *44:01, and 55:01 subgroups might have a protective effect, while HLA-B15, *35, and 51 alleles and HLA-B15:01, *35:01, *35:08, and *51:01 subgroups might play a role in susceptibility to HIV-1 infection.
许多人类白细胞抗原(HLA)-B等位基因与获得性免疫缺陷综合征(AIDS)风险增加及人类免疫缺陷病毒(HIV)进展相关;然而,它们在不同种族/民族群体中的分布存在差异。用于治疗AIDS的阿巴卡韦会显著增加HLA-B57:01患者发生超敏反应的风险。本研究的目的是确定在土耳其与HIV相关的HLA-B亚组(高分辨率和低分辨率)以及与阿巴卡韦敏感性相关的HLA-B57:01的分布情况。
这项回顾性病例对照研究包括416名(女/男:111/305)HIV阳性患者和416名(女/男:111/305)健康对照。使用基于Luminex的低分辨率方法鉴定HLA-B等位基因,并通过基于序列的高分辨率分型进一步进行亚组分析。
我们的数据显示,在HIV-1感染患者中,与对照组相比,HLA-B15、35和51等位基因频率较高,而HLA-B07、14和55等位基因频率较低。确定与对照组相比,HIV-1感染患者中HLA-B*15:01、35:01、35:08和51:01等位基因频率较高,而HLA-B07:02、14:01、44:01和55:01等位基因频率较低。在阿巴卡韦超敏反应中起重要作用的HLA-B57:01等位基因阳性率低于对照组,但这种差异无统计学意义。
我们的结果表明,HLA-B07、14和55等位基因以及HLA-B07:02、14:01、44:01和55:01亚组可能具有保护作用,而HLA-B15、35和51等位基因以及HLA-B*15:01、*35:01、35:08和51:01亚组可能在HIV-1感染易感性中起作用。